Arkema Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Arkema hat ein Gesamteigenkapital von €8.0B und eine Gesamtverschuldung von €4.3B, wodurch sich der Verschuldungsgrad auf 53.6% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen €15.1B bzw. €7.1B. Arkema Das EBIT des Unternehmens beträgt €687.0M, so dass der Zinsdeckungsgrad 28.6 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von €2.3B.

Wichtige Informationen

53.6%

Verhältnis von Schulden zu Eigenkapital

€4.28b

Verschuldung

Zinsdeckungsgrad	28.6x
Bargeld	€2.32b
Eigenkapital	€7.99b
Gesamtverbindlichkeiten	€7.13b
Gesamtvermögen	€15.12b

Jüngste Berichte zur Finanzlage

Recent updates

Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

May 13

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Apr 25

Is Arkema (EPA:AKE) A Risky Investment?

Mar 29

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Mar 08

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Dec 30

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Dec 15

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Nov 29

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Sep 07

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Aug 20

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Aug 02

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

May 28

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

May 13

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

May 09

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Apr 24

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Apr 05

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Feb 26

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Feb 14

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Jan 30

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Jan 14

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Nov 02

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Oct 11

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Jul 19

What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

Jul 04

If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Jun 03

Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's

May 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Apr 25

Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?

Apr 24

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00

Apr 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Mar 27

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Feb 27

Is Now The Time To Put Arkema (EPA:AKE) On Your Watchlist?

Feb 15

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Feb 02

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: AKEDie kurzfristigen Aktiva des Unternehmens (€5.4B) übersteigen seine kurzfristigen Passiva (€2.9B).

Langfristige Verbindlichkeiten: AKEDie kurzfristigen Vermögenswerte des Unternehmens (€5.4B) übersteigen seine langfristigen Verbindlichkeiten (€4.3B).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: AKEDie Nettoverschuldung im Verhältnis zum Eigenkapital (24.6%) wird als zufriedenstellend angesehen.

Schulden abbauen: AKEDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 47.5% auf 53.6% gestiegen.

Schuldendeckung: AKEDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (28.4%).

Zinsdeckung: AKEDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (28.6x Coverage) gut gedeckt.

Arkema Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Recent updates

Consensus EPS estimates fall by 11%

Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of €3.50 per share

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Arkema S.A. (ENXTPA:AKE) agreed to acquire The Dow Chemical Company from Dow Inc. (NYSE:DOW) for an enterprise value of $150 million.

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Dividend increased to €3.50

Consensus EPS estimates fall by 20%

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Full year 2023 earnings: EPS misses analyst expectations

Arkema S.A. to Report Q2, 2024 Results on Aug 01, 2024

Arkema S.A. (ENXTPA:AKE) acquired an unknown minority stake in Tiamat.

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Arkema S.A. (ENXTPA:AKE) acquired Arc Bulding Products.

Arkema S.A. (ENXTPA:AKE) completed the acquisition of 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity.

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Arkema S.A. to Report Q1, 2024 Results on May 07, 2024

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Arkema S.A., Annual General Meeting, May 15, 2024

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Second quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Now 21% undervalued

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates increase by 11%

Arkema S.A. agreed to acquire Polytec PT GmbH Polymere Technologien.

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

Arkema S.A. Appoints Florence Lambert and Séverin Cabannes as Director

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

Upcoming dividend of €3.40 per share at 3.9% yield

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 11%, revenue upgraded

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Full year 2022 earnings: EPS misses analyst expectations

Arkema S.A. Announces Executive Changes

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Prayon S.A. completed the acquisition of Febex S.A from Arkema S.A. (ENXTPA:AKE).

Arkema S.A. to Report Q1, 2023 Results on May 05, 2023

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Prayon S.A. entered into an agreement to acquire Febex S.A from Arkema S.A. (ENXTPA:AKE).

Price target decreased to €104

Price target decreased to €106

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Arkema S.A. (ENXTPA:AKE) acquired Polimeros Especiales, S.A. De C.V.

Arkema S.A. to Report Fiscal Year 2022 Results on Feb 23, 2023

Consensus EPS estimates increase by 12%

Arkema S.A. (ENXTPA:AKE) agreed to acquire Polimeros Especiales, S.A. De C.V.

Consensus EPS estimates increase by 11%

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

Investor sentiment deteriorated over the past week

If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Consensus EPS estimates fall by 10%

Upcoming dividend of €3.00 per share

Consensus EPS estimates increase by 28%

Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's